current user: public




15675963
Query: gi|15675963|ref|NP_273081.1| 6-phosphogluconate dehydrogenase (NMB0015) [Neisseria meningitidis MC58], from N.meningitidis

Results of FFAS03 search in PfamA26U
Master-slave alignment does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480
# Score Template Links and tools%idFirst MNGDIGVIGLAVMGQNLILNMNDCGFKVVAYNRTTAKVDEFLNGAAKGTNIIGAYSLQDLVDKLEKPRKIMMMVRAGSVVDEFIEQLLPLLEEGDILIDGGNANYPDTTRRTHYLAEKGILFVGAGVSGGEEGARRGPSIMPGGDKRAWDAVKPIFQAIAAKTSQGEPCCDWVGKDGAGHFVKMVHNGIEYGDMQLICEAYQFMKDGLGLSYDEMYRVFAEWNKTELDSYLIEITAAILGYKDEGGEPLVEKILDTAGQKGTGKWTGINALDLGIPLTLISEAVFARCVSSFKEQRVQTGKLFARTVTPVEGGKQEWVEALRQALLASKIISYAQGFMLIREAGESYGWDLDYGNTALLWREGCIIRSAFLSNIRDAYENNPDLVFLGADPYFKNILENCLPAWRKVVAKAVECGIPMPCMASAITFLDGYTTERLPANLLQAQRDYFGAHTYERTDKPRGEFFHTNWTGKGGDTASTTYDILast
1 -90.300PF00393.14; 6PGD_SYNY3/189-481; 6-phosphogluconate dehydrogenase, C-terminal domain  ali follow..  50  1..................................................................................................................................................................................GHYVKMVHNGIEYGDMQLIAEAYDILKNGLGLSNEQLHEVFGQWNQDELNSFLIEISTDIFAKKDPTGGHLIDYILDAAGQKGTGRWTVMSGLELGVPIPTIYAAVNARVMSSLKEERVAASGQLSGPSKTFSGDVEAWIPKVRDALYCSKMCSYAQGMALIAKASQEFGYDVNLPEIARIWKGGCIIRAGFLDKIKKAFKDNPQLPNLLLAPEFKQSILDRQGPWREVLMLANEMGIAVPAFSSSLDYFDSYRRAVLPQNLTQAQRDYFGAHTYERTDKPRGEFFHTEW.............. 292
2 -76.100PF03446.10; 6PGD_CUNEL/5-178; NAD binding domain of 6-phosphogluconate dehydrogenase  ali follow..  68  2..ADIGLIGLAVMGQNLILNMNDHGFVVCAYNRTTSKVDDFLANEAKGTNVVGAHSVEELCAKLKRPRKVMLLVKAGSAVDAFIDQLLPHLEEGDIIIDGGNSHFPDSIRRTKELEAKGILFVGSGVSGGEEGARYGPSLMPGGNSKAWEHIQPIFQAIAAKAPDGASCCEWVGE................................................................................................................................................................................................................................................................................................................... 174
3 -10.500PF01210.18; GPDA_COXBU/7-162; NAD-dependent glycerol-3-phosphate dehydrogenase N-terminus  ali follow..  18  1...PIAILGAGSWGTALALVLARKGQKVRLWSYESDHVDEMQAEGVNNRYLPNYKAYCDLKASLEGVTDILIVVPS-FAFHEVITRMKPLIDAKTRIAWGTKGLAKGSRLLHEVVATE--------LGQVPMAVISGPSL-------------------ATEVAANLPTAVSLASNNS................................................................................................................................................................................................................................................................................................................ 153
4 -9.060PF03721.9; P72381_STAAU/1-183; UDP-glucose/GDP-mannose dehydrogenase family, NAD binding domain  ali follow..  16  2...KLTVVGLGYIGLPTSIMFAKHGVDVLGVDINQQTIDKLQSGQISIEEPGLQEVYEEVLSSPEASDVFIIAVPT-SLVMRALDSILPFLEKGNTIIVESTIAPKTMDDFVKPVIEN------LGFTIGED-LVHCPEVLPGKILEELVHNNRIIGGVTKACIE............................................................................................................................................................................................................................................................................................................................. 178
5 -9.020PF10727.4; A0QA92_MYCA1/1-128; Rossmann-like domain  ali follow..  13  11.RLKVGIISAGRVGTALGVALERADHVVVCSAISHASRQRAQRRLPD----TPVATPPEVAAGAE----LLLLAVPDSELAGLVSGLTEAVRAGTIVAHTSGANGVGIL---APLTRQGCIPLAI..................................................................................................................................................................................................................................................................................................................................................................... 126
6 -8.500PF02558.11; Q9K9R6_BACHD/6-154; Ketopantoate reductase PanE/ApbA  ali follow..  14  1....VAVIGSGSIGLLLYAYLKLANWPALLVTNRPEQADHLFVAKSGEHQPISVTATPLSSFSAEEAEVGFITVKSFA-VKALLPQLQRKKWDGLVFFQNGMTHLEILRQIPARAICCGIVEIGAKRESDVRVQHTGDGAIWIGDMVG.............................................................................................................................................................................................................................................................................................................................................. 149
7 -7.360PF03807.12; Q21544_CAEEL/2-98; NADP oxidoreductase coenzyme F420-dependent  ali follow..  19  1...KIGFIGAGKMAQALARGLINSGRNIIASSPKRDEVFLDQCKA------LGLNTTHDNAEVVQKSDVVFLAVKP-VHVSKVASEIAPALSKEHLVVS............................................................................................................................................................................................................................................................................................................................................................................................... 93
8 -7.230PF02254.13; Q721E3_LISMF/5-120; TrkA-N domain  ali follow..  22  1....FAVIGLGRFGGSICRSLVEQGMEVLAIDSDEERVNEYMSIATHA--VIANSTDENALRQLGIRNFEHVIVAIGEDIQSSILTTLILKEMG.................................................................................................................................................................................................................................................................................................................................................................................................... 88
9 -5.910PF02826.14; Q98GE4_RHILO/107-283; D-isomer specific 2-hydroxyacid dehydrogenase, NAD binding domain  ali follow..  18  39..KTIGIVGLGAVGQAVGIAAHGFDLKVVATTRSMQPAPEKVG-------------FLSIDALVEQSDIIVLCCPLTPETRGLISERIARMKPNALLINVSRGPVVDDDALIEALREGRIGGAALDVFSTQPLSYNHPYF...................................................................................................................................................................................................................................................................................................................................................... 165
10 -5.420PF02737.13; Q8YJI4_BRUME/5-184; 3-hydroxyacyl-CoA dehydrogenase, NAD binding domain  ali follow..  16  1...TVGIIGAGQMGSGIAHVCALAGYNVLLHDAAPDRLEKGIAARQVASGKLQEEQRADAMKLIRPANSMEDLAGVDLAIEAATEQLCPVLNPEAILATNTSSISITRLASTTDRPERGIHFMN...................................................................................................................................................................................................................................................................................................................................................................... 139

FFAS is supported by the NIH grant R01-GM087218-01
6 0 9 8 5   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster
Locations of visitors to this page
Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Friedberg I, Harder T, Kolodny R, Sitbon E, Li Z, Godzik A. Using an alignment of fragment strings for comparing protein structures. Bioinformatics. 2007 Jan 15;23(2):e219-24.